Get started
Author

Silvia della Torre

Observed names: S della Torre, S. Della Torre, Silvia Della Torre
ORCID: 0000-0003-3840-7888
Observed ORCID: 0000-0003-3840-7888
OpenAlex ID: A5105423514
Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women
2005 · Emilio Bajetta, Giuseppe Procopio, et al. · Journal of Clinical Oncology · 208
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?
2005 · E. Bajetta, L. Catena, et al. · Annals of Oncology · 75
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
2016 · On behalf of VICTOR Study Group, M. E. Cazzaniga, et al. · Breast Cancer Research and Treatment · 60
PDF
Treatment Options in Hormone-refractory Metastatic Prostate Carcinoma
2004 · Alberto Fusi, Giuseppe Procopio, et al. · Tumori Journal · 40
A randomized, multicenter prospective trial assessing long‐acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma
2002 · Emilio Bajetta, Giuseppe Procopio, et al. · Cancer · 36
Accuracy and Clinical Correlates of Two Different Methods for Chromogranin A Assay in Neuroendocrine Tumors
2004 · L. Ferrari, E. Seregni, et al. · The International Journal of Biological Markers · 32
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach
2024 · Valeria Calcaterra, Sara Zanelli, et al. · Diseases · 15
PDF
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
2017 · M. E. Cazzaniga, L. Cortesi, et al. · International Journal of Breast Cancer · 15
PDF
Kit Protein (CD 117) and Proliferation Index (Ki-67) Evaluation in Well and Poorly Differentiated Neuroendocrine Tumors
2006 · Leonardo Ferrari, Silvia Della Torre, et al. · Tumori Journal · 15
Exploring the administrative burden faced by hematologists: a comprehensive study in Italy
2024 · Davide Petruzzelli, Marco Vignetti, et al. · Global & Regional Health Technology Assessment · 8
PDF
Current Treatments of Neuroendocrine Tumors Role of Biotherapy and Chemotherapy
2003 · Silvia Della Torre, Giuseppe Procopio, et al. · Tumori Journal · 7
Safety and activity of Capecitabine in elderly patients with advanced breast cancer
2001 · G. Procopio, E. Bajetta, et al. · European Journal of Cancer · 7
Case Report of Synchronous Multicentric Osteosarcoma and Review of the Literature: The Importance of Autopsy for Diagnosis
2005 · Roberto Buzzoni, Silvia Della Torre, et al. · Tumori Journal · 6
Vaccination in Oncology Patients: Evidence, Clinical Challenges, and Future Directions
2026 · Alberto Giuseppe Agostara, Silvia Della Torre, et al. · Vaccines · 3
PDF
Long-term complete response in metastatic poorly-differentiated neuroendocrine rectal carcinoma with a multimodal approach: A case report
2021 · Silvia Della Torre, Germana de Nucci, et al. · World Journal of Clinical Oncology · 3
117 Oxaliplatin plus capecitabine in advanced neuroendocrine tumours (NETs): Is the new WHO classification applicable to daily practice?
2003 · L. Catena, E. Bajetta, et al. · European Journal of Cancer Supplements · 3
Enhancing Herpes Zoster Vaccination Rates Among Oncology Outpatients: Impact of an In-House Vaccination Initiative
2025 · Alberto Giuseppe Agostara, Silvia Della Torre, et al. · Cancers · 2
PDF
Endoscopic ultrasound-guided radiofrequency ablation for treatment of pancreatic neuroendocrine tumors: Multicenter prospective study
2025 · Gianenrico Rizzatti, Bertrand Napoléon, et al. · Endoscopy International Open · 2
PDF
Effects of three products in the prevention and treatment of chemotherapy and radiation therapy-induced oral mucositis
2019 · F. Zannier, S. Di Bella, et al. · Annals of Oncology · 2
451 Elderly patients with advanced breast cancer: safety and efficacy of capecitabine
2003 · G. Procopio, E. Bajetta, et al. · European Journal of Cancer Supplements · 2
Kounis Syndrome Induced by Atezolizumab in a Patient with Non-Small Cell Lung Cancer: A Case Report
2025 · Alberto Giuseppe Agostara, Sara Di Bella, et al. · Case Reports in Oncology · 1
PDF
1588P Interventions to improve Herpes Zoster (HZ) vaccination rate among cancer outpatients receiving systemic treatments: A single-center real-world experience
2024 · S. Di Bella, A.G. Agostara, et al. · Annals of Oncology · 1
Long Term Complete Response in Metastatic Poorly-Differentiated Neuroendocrine Rectal Carcinoma With Multimodal Approach: A Case Report
2021 · G de Nucci, S della Torre, et al. · Endoscopy · 1
Po64 Metronomic Chemotherapy (cht) Combination of Vinorelbine (vrl) and Capecitabine (cape) in Her2- Advanced Breast Cancer (abc) Patients (pts) Does Not Impair Global Qol. First Results of the Victor-2 Study
2015 · Marina Elena Cazzaniga, Valter Torri, et al. · The Breast · 1
Second-line chemoterapy in advanced gastric cancer patients
2015 · P. Belloni, C. Cozzi, et al. · Annals of Oncology · 1
PDF
Works count: 41
Citation count: 547
H-index: 9
I10-index: 9
Year
Topic
Type